Text Messaging Support for HIV
Trial Summary
What is the purpose of this trial?
Text Me, Alexis! is a three-arm randomized controlled trial (RCT) to determine the optimal and most cost-effective intervention for advancing trans women living with HIV to full viral suppression. Participants will be randomized (1:1:1) to Peer Health Navigation (PHN) alone, SMS (text messaging) alone, or PHN+SMS. Participants in the PHN alone and PHN+SMS arms will receive unlimited navigation sessions over 3 months. Participants in the SMS alone and PHN+SMS arms will receive 3 daily theory-based text messages for 90 days for a total of 270 unique scripted messages.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on supporting HIV care through text messaging and peer navigation, so it's likely you can continue your current medications.
What data supports the effectiveness of the treatment Text Me, Alexis! for HIV?
Is text messaging support for HIV treatment safe for humans?
How does the 'Text Me, Alexis!' treatment for HIV differ from other treatments?
The 'Text Me, Alexis!' treatment is unique because it uses text messaging to support people with HIV, helping them stay engaged in their care and manage their condition. Unlike traditional treatments that focus on medication, this approach leverages technology to provide reminders and encouragement, which can be especially beneficial in urban settings where access to consistent care may be challenging.59101112
Research Team
Cathy J Reback, PhD
Principal Investigator
Friends Research Institute, Inc.
Sean M Murphy, PhD
Principal Investigator
Weill Medical College of Cornell University
Eligibility Criteria
This trial is for trans women living with HIV/AIDS. Participants should be interested in interventions aimed at achieving full viral suppression. The study excludes individuals who do not meet the inclusion criteria set by the researchers, which are not specified here.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Peer Health Navigation (PHN), SMS text messaging, or a combination of both for 90 days
Follow-up
Participants are monitored for safety and effectiveness after treatment with assessments at 3, 6, 12, and 18 months post-enrollment
Treatment Details
Interventions
- Text Me, Alexis! (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Friends Research Institute, Inc.
Lead Sponsor
Dr. Steven Carswell
Friends Research Institute, Inc.
Chief Executive Officer
PhD
Dr. Robert Schwartz
Friends Research Institute, Inc.
Chief Medical Officer since 2023
MD
Weill Medical College of Cornell University
Collaborator
Dr. Robert Min
Weill Medical College of Cornell University
Chief Executive Officer since 2024
MD, MBA
Dr. Adam R. Stracher
Weill Medical College of Cornell University
Chief Medical Officer since 2024
MD